Aldeyra Therapeutics, Inc. (ALDX) SEC filings
ALDX SEC filings moved a median of +0.40% by the close. ALDX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ALDX overview →
66 measured ALDX SEC filing events.
Where these ALDX SEC filings landedvs 64 measured ALDX SEC filing reactions
| Middle 50% of ALDX SEC filing reactions | -1.69% to +3.37% |
|---|---|
| Median reaction (to close) | +0.40% |
| Measured reactions | 64 |
Point-in-time · zero look-ahead
Half of the 64 ALDX SEC filing events with a measured close landed between -1.69% and +3.37%; 53% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Aldeyra Therapeutics, For: Sep 29 | SEC filing · Form 8-K | +2.56% | +12.82% | |
| Form 10-Q Aldeyra Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.64% | -0.64% | |
| Form 8-K Aldeyra Therapeutics, For: Jul 28 | SEC filing · Form 8-K | -0.62% | -4.94% | |
| Form 8-K Aldeyra Therapeutics, For: Jul 14 | SEC filing · Form 8-K | -10.05% | -6.52% | |
| Form 8-K Aldeyra Therapeutics, For: Jun 09 | SEC filing · Form 8-K | +0.58% | -1.17% | |
| Form 10-Q Aldeyra Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.53% | +1.76% | |
| Form 8-K Aldeyra Therapeutics, For: May 01 | SEC filing · Form 8-K | -0.28% | +2.62% | |
| Form ARS Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.90% | -0.63% | |
| Form DEF 14A Aldeyra Therapeutics, For: Jun 10 | SEC filing · Form DEF | +1.90% | -0.63% | |
| Form DEFA14A Aldeyra Therapeutics, | SEC filing · Form DEFA14A | +1.90% | -0.63% | |
| Form 8-K Aldeyra Therapeutics, For: Apr 20 | SEC filing · Form 8-K | -0.56% | -6.14% | |
| Form 8-K Aldeyra Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -2.36% | -1.77% | |
| Form 8-K Aldeyra Therapeutics, For: Mar 17 | SEC filing · Form 8-K | +5.31% | +9.73% | |
| Form 10-K Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.15% | +4.07% | |
| Form S-8 Aldeyra Therapeutics, | SEC filing · Form S-8 | +3.15% | +4.07% | |
| Form 8-K Aldeyra Therapeutics, For: Dec 23 | SEC filing · Form 8-K | +0.78% | -8.79% | |
| Form 8-K Aldeyra Therapeutics, For: Dec 15 | SEC filing · Form 8-K | +5.32% | +34.43% | |
| Form 8-K Aldeyra Therapeutics, For: Nov 13 | SEC filing · Form 8-K | -1.80% | — | |
| Form 10-Q Aldeyra Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.91% | -2.43% | |
| Form 8-K Aldeyra Therapeutics, For: Oct 28 | SEC filing · Form 8-K | -3.12% | +0.20% | |
| Form 8-K Aldeyra Therapeutics, For: Aug 19 | SEC filing · Form 8-K | +0.74% | — | |
| Form 10-Q Aldeyra Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.45% | +1.94% | |
| Form 8-K Aldeyra Therapeutics, For: Jul 17 | SEC filing · Form 8-K | +1.35% | -3.27% | |
| Form 8-K Aldeyra Therapeutics, For: Jun 26 | SEC filing · Form 8-K | +2.17% | +5.16% | |
| Form 8-K Aldeyra Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +2.46% | +1.31% | |
| Form 8-K Aldeyra Therapeutics, For: Jun 10 | SEC filing · Form 8-K | -1.35% | -1.01% | |
| Form 10-Q Aldeyra Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -2.33% | -1.37% | |
| Form 8-K Aldeyra Therapeutics, For: May 05 | SEC filing · Form 8-K | -14.56% | -12.86% | |
| Form ARS Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form ARS | +1.87% | +3.37% | |
| Form DEF 14A Aldeyra Therapeutics, For: Jun 10 | SEC filing · Form DEF | +1.87% | +3.37% | |
| Form DEFA14A Aldeyra Therapeutics, | SEC filing · Form DEFA14A | +1.87% | +3.37% | |
| Form 8-K Aldeyra Therapeutics, For: Apr 17 | SEC filing · Form 8-K | -1.39% | +3.70% | |
| Form 8-K Aldeyra Therapeutics, For: Apr 03 | SEC filing · Form 8-K | +13.03% | +33.10% | |
| Form 10-K/A Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.23% | -11.95% | |
| Form 10-K Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +10.50% | +15.65% | |
| Form S-8 Aldeyra Therapeutics, | SEC filing · Form S-8 | +10.50% | +15.65% | |
| Form 8-K Aldeyra Therapeutics, For: Nov 15 | SEC filing · Form 8-K | +2.87% | -3.69% | |
| Form 10-Q Aldeyra Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.21% | +2.79% | |
| Form 8-K Aldeyra Therapeutics, For: Oct 03 | SEC filing · Form 8-K | +0.19% | -1.32% | |
| Form 8-K Aldeyra Therapeutics, For: Sep 30 | SEC filing · Form 8-K | +0.19% | -1.32% | |
| Form 8-K Aldeyra Therapeutics, For: Aug 29 | SEC filing · Form 8-K | +0.88% | +1.58% | |
| Form 8-K Aldeyra Therapeutics, For: Aug 08 | SEC filing · Form 8-K | -6.58% | +14.79% | |
| Form 10-Q Aldeyra Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.44% | +0.72% | |
| Form 8-K Aldeyra Therapeutics, For: Aug 01 | SEC filing · Form 8-K | -3.44% | +0.72% | |
| Form 8-K Aldeyra Therapeutics, For: Jun 20 | SEC filing · Form 8-K | -12.54% | -5.43% | |
| Form 8-K Aldeyra Therapeutics, For: Jun 13 | SEC filing · Form 8-K | -0.25% | -2.03% | |
| Form 8-K Aldeyra Therapeutics, For: Jun 04 | SEC filing · Form 8-K | -0.36% | +0.52% | |
| Form 10-Q Aldeyra Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.18% | -1.66% | |
| Form 8-K Aldeyra Therapeutics, For: Apr 25 | SEC filing · Form 8-K | +0.92% | +1.03% | |
| Form EFFECT Aldeyra Therapeutics, | SEC filing · Form EFFECT | +0.92% | +1.03% | |
| Form ARS Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.51% | -0.76% | |
| Form DEF 14A Aldeyra Therapeutics, For: Jun 04 | SEC filing · Form DEF | +0.51% | -0.76% | |
| Form DEFA14A Aldeyra Therapeutics, | SEC filing · Form DEFA14A | +0.51% | -0.76% | |
| Form 8-K Aldeyra Therapeutics, For: Mar 28 | SEC filing · Form 8-K | +4.01% | +4.81% | |
| Form 10-K Aldeyra Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.59% | -4.23% | |
| Form S-3 Aldeyra Therapeutics, | SEC filing · Form S-3 | +1.59% | -4.23% | |
| Form S-8 Aldeyra Therapeutics, | SEC filing · Form S-8 | +1.59% | -4.23% | |
| Form S-8 POS Aldeyra Therapeutics, | SEC filing · Form S-8 | +1.59% | -4.23% | |
| Form 8-K Aldeyra Therapeutics, For: Feb 13 | SEC filing · Form 8-K | +1.86% | +5.59% | |
| Form 8-K Aldeyra Therapeutics, For: Jan 04 | SEC filing · Form 8-K | -0.59% | -1.18% | |
| Form 8-K Aldeyra Therapeutics, For: Dec 21 | SEC filing · Form 8-K | +3.71% | +0.29% | |
| Form 8-K Aldeyra Therapeutics, For: Dec 19 | SEC filing · Form 8-K | -1.42% | +2.04% | |
| Form 8-K Aldeyra Therapeutics, For: Nov 27 | SEC filing · Form 8-K | +1.59% | +7.14% | |
| Form 10-Q Aldeyra Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.79% | +0.90% | |
| Form S-8 Aldeyra Therapeutics, | SEC filing · Form S-8 | +0.79% | +0.90% | |
| Form 8-K Aldeyra Therapeutics, For: Oct 31 | SEC filing · Form 8-K | +6.03% | +27.64% |
Keep exploring
More ALDX: earnings → · analyst actions → · ALDX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| HEMISPHERX BIOPHARMA (HEB) | 779 | -0.06% | 42% |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) | 777 | -0.09% | 47% |
| CYTORI THERAPEUTICS (CYTX) | 774 | -0.72% | 32% |
| Adamis Pharmaceuticals Corporation (ADMP) | 772 | -0.47% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.